Truong-Son Dinh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Truong-Son Dinh has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Cat-Tram Nguyen
University of Medicine and Pharmacy at Ho Chi Minh City
1 shared publication - Duc-Tuan Nguyen
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 41-43 Đinh Tien Hoang, Saigon Ward, Ho Chi Minh City 700000, Vietnam
1 shared publication - Hoang-Han Do
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
1 shared publication - Huynh Nhu Mai
University of Medicine and Pharmacy at Ho Chi Minh City
1 shared publication - Kien Duc Ngo
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
1 shared publication - Minh-Quan Le
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
1 shared publication
Latest Publications
- Open Access
- 28 January 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (1)
Extraction Optimization, Chemical Characterization , Xanthine Oxidase Inhibitory and Hypouricemic Activities for the Gout Treatment of the Extracts from Cosmos sulphureus Cav. flowers
Objectives: Cosmos sulphureus Cav. has a rich history of traditional medicinal use in Southeast Asia, particularly for the treatment of diabetes, high blood pressure, inflammation and infections. This study aimed to optimize flavonoid extraction and evaluate the hypouricemic effects for the gout treatment of the extracts from the flowers of CS. Methods: Extraction optimization was conducted using response surface methodology with a factorial design that included two variables – ethanol concentration (25%–70%) and solvent-to-material ratio (10-20 mL/g) - and three responses: extraction efficiency, total flavonoid content (TFC), and IC 5 0 values for xanthine oxidase inhibition. Toxicity studies followed the Guidelines for Preclinical and Clinical Trials of Traditional Medicine and Herbal Medicines issued by the Vietnam Ministry of Health as well as the OECD (2001) with minor modifications. The pharmacological activity was assessed in acute and chronic potassium oxonate–induced hyperuricemia models. Results: The optimization CS extraction conditions were identified as percolation using 70% ethanol with a solvent-to-material ratio of 20 mL/g. The extraction process was successfully scaled up to 1 kg of raw material per batch, demonstrating its stability and applicability for further pharmacological studies. Chemical characterization confirmed the extract was rich in flavonoids, with coreopsin and luteolin identified as major constituents. In a model of acute and chronic hyperuricemia induced by potassium oxonate (i.p), the 250 mg/kg CS flower extract demonstrated uric acid-lowering effects similar to the reference drug allopurinol at 10 mg/kg. Conclusions: These findings highlight the novelty of using Cosmos sulphureus Cav. as a potent natural source for anti-hyperuricemic agents, supporting its potential for pharmaceutical development.
- 28 January 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (1)
Open AccessExtraction Optimization, Chemical Characterization , Xanthine Oxidase Inhibitory and Hypouricemic Activities for the Gout Treatment of the Extracts from Cosmos sulphureus Cav. flowers
Objectives: Cosmos sulphureus Cav. has a rich history of traditional medicinal use in Southeast Asia, particularly for the treatment of diabetes, high blood pressure, inflammation and infections. This study aimed to optimize flavonoid extraction and evaluate the hypouricemic effects for the gout treatment of the extracts from the flowers of CS. Methods: Extraction optimization was conducted using response surface methodology with a factorial design that included two variables – ethanol concentration (25%–70%) and solvent-to-material ratio (10-20 mL/g) - and three responses: extraction efficiency, total flavonoid content (TFC), and IC 5 0 values for xanthine oxidase inhibition. Toxicity studies followed the Guidelines for Preclinical and Clinical Trials of Traditional Medicine and Herbal Medicines issued by the Vietnam Ministry of Health as well as the OECD (2001) with minor modifications. The pharmacological activity was assessed in acute and chronic potassium oxonate–induced hyperuricemia models. Results: The optimization CS extraction conditions were identified as percolation using 70% ethanol with a solvent-to-material ratio of 20 mL/g. The extraction process was successfully scaled up to 1 kg of raw material per batch, demonstrating its stability and applicability for further pharmacological studies. Chemical characterization confirmed the extract was rich in flavonoids, with coreopsin and luteolin identified as major constituents. In a model of acute and chronic hyperuricemia induced by potassium oxonate (i.p), the 250 mg/kg CS flower extract demonstrated uric acid-lowering effects similar to the reference drug allopurinol at 10 mg/kg. Conclusions: These findings highlight the novelty of using Cosmos sulphureus Cav. as a potent natural source for anti-hyperuricemic agents, supporting its potential for pharmaceutical development.